Assessment of ECS, an additional prognosticator in advanced stage disease, indicated a distinct set of markers in tongue cancer (EXT1, GMPS, TSTA3), while in laryngopharyngeal cancers a majority of the markers were common those associated with late stage disease. Here, GMPS is linked to tongue cancer.